Vistin Pharma ASA (VISTN): Update from the Election Committee

Group 1 - Øystein Stray Spetalen has requested not to be re-elected as a board member of Vistin Pharma ASA [1] - The Election Committee assessed the implications of this request and concluded that Spetalen will not be replaced, resulting in a reduction of one board member [2] - The recommendation submitted on 13 March 2025 remains unchanged, except for the withdrawal of Item 9 from the annual general meeting agenda [2][3]